The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.
The biotech group struggled as a whole in 2024, but analysts say the innovation that has always supported the biotech ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ALG-801, Alivegen ’s experimental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback